Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-21-000683
Filing Date
2021-01-29
Accepted
2021-01-29 16:12:40
Documents
1

Document Format Files

Seq Description Document Type Size
1 JOUNCE THERAPEUTICS, INC. p21-0358sc13g.htm SC 13G 104418
  Complete submission text file 0000902664-21-000683.txt   106011
Mailing Address 200 CLARENDON STREET, 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116 (617) 867-2800
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by) CIK: 0001165408 (see all company filings)

EIN.: 043574590 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Subject) CIK: 0001640455 (see all company filings)

EIN.: 454870634 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89831 | Film No.: 21571314
SIC: 2836 Biological Products, (No Diagnostic Substances)